CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Developing and commercializing active ingredients from natural sources for healthcare and personal care industries.
Learn More about our ProductsPGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View PresentationCeapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event
Jan 10, 2023 | Read More
Ceapro Announces Grant of Stock Options
Jan 4, 2023 | Read More
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
Dec 22, 2022 | Read More
Ceapro Inc. Reports 2022 Third Quarter and Nine-Month Financial Results and Operational Highlights
Nov 9, 2022 | Read More